Metabolomics can identify predictive and actionable biomarker profiles from a child’s inherited biochemistry as well as the interactions of the gut microbiome with dietary and environmental factors that may contribute to ASD. Identification of metabolic profiles in children with ASD creates an opportunity to develop metabolic based diagnostics that enable early diagnosis and elucidate biochemical changes associated with ASD. View the poster here.
Presented at the International Society for Autism Research (INSAR) Annual Meeting in Rotterdam, Netherlands; May 2018. NeuroPointDX’s autism